Zhong Zheng1, Jia Jian1, Omar Velasco1, Ching-Yun Hsu1, Kermit Zhang1, Andrew Levin1, Maxwell Murphy1, Xinli Zhang1, Kang Ting1, Chia Soo1. 1. Dental and Craniofacial Research Institute and Division of Growth and Development, Section of Orthodontics, School of Dentistry, University of California, Los Angeles, Los Angeles, Calif.; UCLA Division of Plastic and Reconstructive Surgery and Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, University of California, Los Angeles, Los Angeles, Calif.; and Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, Calif.
Abstract
BACKGROUND: Fibromodulin (FMOD) plays a critical role in the wound-healing process. Our previous studies revealed that FMOD deficiency led to marked alterations in adult wound healing characterized by delayed dermal cell migration, postponed wound closure, and increased scar formation, all accompanied by impeded angiogenesis. Therefore, the aim of this study was to reveal the effect of FMOD on angiogenesis during the wound-healing process. METHODS: In vivo angiogenic effects of FMOD were assessed by a chick embryo chorioallantoic membrane assay, a Matrigel (BD Bioscience, Franklin Lakes, N.J.) plug implant assay, and rodent primary closure wound models. In vitro angiogenic effects of FMOD were recorded by cell invasion and dimensional and topological parameters of human umbilical vein endothelial cells. RESULTS: We provided evidence that FMOD significantly enhanced vascularization: first, FMOD boosted blood vessel formation on the chorioallantoic membrane; second, FMOD markedly stimulated capillary infiltration into Matrigel plugs subcutaneously implanted in adult mice; and finally, FMOD robustly promoted angiogenesis in multiple adult rodent cutaneous wound models. Furthermore, FMOD administration restored the vascularity of fmod (-/-) mouse wounds. In support of this, FMOD endorsed an angiogenesis-favored microenvironment in adult rodent wounds not only by upregulating angiogenic genes but also by downregulating angiostatic genes. In addition, FMOD significantly enhanced human umbilical vein endothelial cell invasion and tube-like structure formation in vitro. CONCLUSIONS: Altogether, we demonstrated that in addition to reducing scar formation, FMOD also promotes angiogenesis. As blood vessels organize and regulate wound healing, its potent angiogenic properties will further expand the clinical application of FMOD for cutaneous healing of poorly vascularized wounds.
BACKGROUND:Fibromodulin (FMOD) plays a critical role in the wound-healing process. Our previous studies revealed that FMOD deficiency led to marked alterations in adult wound healing characterized by delayed dermal cell migration, postponed wound closure, and increased scar formation, all accompanied by impeded angiogenesis. Therefore, the aim of this study was to reveal the effect of FMOD on angiogenesis during the wound-healing process. METHODS: In vivo angiogenic effects of FMOD were assessed by a chick embryo chorioallantoic membrane assay, a Matrigel (BD Bioscience, Franklin Lakes, N.J.) plug implant assay, and rodent primary closure wound models. In vitro angiogenic effects of FMOD were recorded by cell invasion and dimensional and topological parameters of human umbilical vein endothelial cells. RESULTS: We provided evidence that FMOD significantly enhanced vascularization: first, FMOD boosted blood vessel formation on the chorioallantoic membrane; second, FMOD markedly stimulated capillary infiltration into Matrigel plugs subcutaneously implanted in adult mice; and finally, FMOD robustly promoted angiogenesis in multiple adult rodent cutaneous wound models. Furthermore, FMOD administration restored the vascularity of fmod (-/-) mouse wounds. In support of this, FMOD endorsed an angiogenesis-favored microenvironment in adult rodent wounds not only by upregulating angiogenic genes but also by downregulating angiostatic genes. In addition, FMOD significantly enhanced human umbilical vein endothelial cell invasion and tube-like structure formation in vitro. CONCLUSIONS: Altogether, we demonstrated that in addition to reducing scar formation, FMOD also promotes angiogenesis. As blood vessels organize and regulate wound healing, its potent angiogenic properties will further expand the clinical application of FMOD for cutaneous healing of poorly vascularized wounds.
Authors: N Sato; H Nariuchi; N Tsuruoka; T Nishihara; J G Beitz; P Calabresi; A R Frackelton Journal: J Invest Dermatol Date: 1990-12 Impact factor: 8.551
Authors: N Tsuruoka; M Sugiyama; Y Tawaragi; M Tsujimoto; T Nishihara; T Goto; N Sato Journal: Biochem Biophys Res Commun Date: 1988-08-30 Impact factor: 3.575
Authors: Zhong Zheng; Xinli Zhang; Catherine Dang; Steven Beanes; Grace X Chang; Yao Chen; Chen-Shuang Li; Kevin S Lee; Kang Ting; Chia Soo Journal: Am J Pathol Date: 2016-09-22 Impact factor: 4.307
Authors: Zhong Zheng; Aaron W James; Chenshuang Li; Wenlu Jiang; Joyce Z Wang; Grace X Chang; Kevin S Lee; Feng Chen; Emily A Berthiaume; Yao Chen; Hsin Chuan Pan; Eric C Chen; Weiming Li; Zhihe Zhao; Xinli Zhang; Kang Ting; Chia Soo Journal: Signal Transduct Target Ther Date: 2017-10-13
Authors: Magdalena Kulus; Wiesława Kranc; Katarzyna Wojtanowicz-Markiewicz; Piotr Celichowski; Agata Światły-Błaszkiewicz; Eliza Matuszewska; Patrycja Sujka-Kordowska; Aneta Konwerska; Maciej Zdun; Rut Bryl; Maria Wieczorkiewicz; Jakub Kulus; Bogusława Stelmach; Katarzyna Stefańska; Joanna Budna-Tukan; James N Petitte; Paul Mozdziak; Kornel Ratajczak; Jan Matysiak; Jędrzej M Jaśkowski; Michał Nowicki; Bartosz Kempisty Journal: Int J Mol Sci Date: 2021-02-19 Impact factor: 5.923